Webhaber
FDA Seeks More Data on Lilly's Alzheimer's Drug Candidate

FDA Seeks More Data on Lilly's Alzheimer's Drug Candidate

The setback could delay a potential commercial introduction of the drug by at least several months, if the FDA eventually decides to approve it.

Wall Street Journal Wall Street Journal | Go to detail of news source

Wall Street Journal, Benzer haberler

Wall Street Journal U.S. Appeals Court Sides With Drugmakers on Discount Program U.S. Appeals Court Sides With Drugmakers on Discount Program
Wall Street Journal 3M Investor Raises Concerns About Company Leadership 3M Investor Raises Concerns About Company Leadership
Wall Street Journal Labor Report to Give Fed Look at Wage Inflation Labor Report to Give Fed Look at Wage Inflation
Wall Street Journal Peloton Narrows Losses as Sales Fall Less Than Forecast Peloton Narrows Losses as Sales Fall Less Than Forecast
Wall Street Journal Eli Lilly Posts 9% Sales Drop on Covid-Treatment Decline Eli Lilly Posts 9% Sales Drop on Covid-Treatment Decline
Wall Street Journal Activist Ryan Cohen Targets a Familiar Foe at Nordstrom Activist Ryan Cohen Targets a Familiar Foe at Nordstrom